Especially, AML derived EVs (positive for CD11c and CD133), ALL derived EVs (positive for CD45, HLA-DRDPDQ) and CLL derived EVs (positive for CD11c and CD146) were found in higher fold-changes compared to EVs derived from healthy samples. This evidence concerns the gene MCAM and B-cell chronic lymphocytic leukemia.